Stephen Cutler, Ph.D. has been appointed senior vice president and chief operating officer, Kendle. Dr. Cutler has more than 20 years of senior management and operations leadership experience in the CRO and biopharmaceutical industries. He will provide global leadership for the company's worldwide late-stage operations, leveraging Phase II-IV capabilities to maximize integrated service offerings for customers. He replaces Chris Bergen, who has been appointed executive vice president and chief administrative officer. Dr. Cutler will report directly to chairman and chief executive officer, Candace Kendle, Pharm.D.

Dr. Cutler joins the company following 14 years with Quintiles, where he most recently served as senior vice president, global project management, responsible for more than 600 people and 500 active projects spanning all therapeutic areas. Previously, he was senior vice president, clinical, medical and regulatory, leading more than 1,200 associates based in North America with responsibility for approximately 200 projects. Dr. Cutler also served as senior vice president, project management, Europe, and vice president, oncology, Europe, and held regional leadership positions in South Africa and Australia.

Mr. Bergen will provide dedicated executive leadership for strategic technology and infrastructure enhancement initiatives with a focus on innovation, productivity and global connectivity.

Other recent executive moves include the appointment of Simon Higginbotham as senior vice president and chief marketing officer, adding to his leadership role in the company's early-stage business, and the appointments of Jarrod Pontius as vice president, chief legal officer and secretary, and Keith Cheesman as senior vice president and chief financial officer.

Sign up today for Contracting & Outsourcing 2009!
www.contractpharma.com/2009conference

News from our sister sites